Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

your timeline is helpful. have said over and over that the trial we need for B is prophylaxis or very early in its course- an ED study with IV would have been good, when people are not very ill and not sick long at all- earlier in the course of illness. Or prophylaxis with a spray or inhaler - but these may never get developed.

The problem of course is that there is no data about the antiinflammatory impact of B v C- NONE. It is being discovered right now as we speak, mostly in Russia.

We can only hope there will be some benefit in patients who are hospitalized and quite ill. It is totally undiscovered country.